Evidence map›Paper›PMID 37111347›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Imageological/Structural Study regarding the Improved Pharmacokinetics by

Huihui Zhang, Maohua Rao, Huayi Zhao, Jianli Ren, Lan Hao, Meng Zhong, Yue Chen, Xia Yang, Yue Feng, Gengbiao Yuan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Huihui ZhangDepartment of Nuclear Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Maohua RaoDepartment of Nuclear Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Huayi ZhaoDepartment of Nuclear Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Jianli RenChongqing Key Laboratory of Ultrasound Molecular Imaging, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Lan HaoChongqing Key Laboratory of Ultrasound Molecular Imaging, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Meng ZhongDepartment of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou 646600, China.
Yue ChenNuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou 646600, China.ORCID 0000-0003-4088-7649
Xia YangInstitute of Nuclear Physics and Chemistry, Academy of Engineering Physics, Mianyang 621900, China.
Yue FengNuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou 646600, China.ORCID 0000-0002-5622-0016
Gengbiao YuanDepartment of Nuclear Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Dalian Medical University · CNFirst Affiliated Hospital of Sichuan Medical University · CNAffiliated Hospital of Southwest Medical University · CNChina Academy of Engineering Physics · CN

Funding

Basic Research and Frontier Exploration of Chongqing Science and Technology Commission Grant No. cstc2018jcyjAX0747Department of Nuclear Medicine at The Second Affiliated Hospital of Chongqing Medical Uni-versity, The National Natural Science Foundation of China (NSFC) Grant No. 31630026, 81630047 and 81873901Open Project Program of Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province HYX20001
6 · The paper itself

Abstract

PMSA (prostate-specific membrane antigen) is currently the most significant target for diagnosing and treating PCa (prostate cancer). Herein, we reported a series

Indexed as

molecular probePET imagingprostate cancerPSMAPSMA dimer

Identifiers

PMID37111347
PMCPMC10144514
OpenAlexW4365509441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.